Recruitment commenced for two larger studies on MS, and a phase I open‐label basket study is underway to evaluate BCMA‐directed CAR‐T cells in various antibody‐associated inflammatory diseases, including MOG‐associated diseases. Here, MOG is linked to myeloid sarcoma.